Morphine Adverse Reaction Completed Phase 4 Trials for Ondansetron (DB00904)

IndicationStatusPhase
DBCOND0043635 (Morphine Adverse Reaction)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03035942Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine AdministrationPrevention